What is HER2?
- 1 March 2000
- journal article
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 4, 2-9
- https://doi.org/10.1054/ejon.2000.0072
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Quantitation of c-erbB-2 in primary breast cancer allows identification of a further poor prognostic groupEuropean Journal Of Cancer, 1999
- Quantitation of EGFR and c-erbB-2 expression in preinvasive compared to invasive breast cancerEuropean Journal Of Cancer, 1999
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cellsCell, 1992
- Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptorsEuropean Journal Of Cancer, 1992
- Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?European Journal Of Cancer, 1992
- Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancerMolecular Carcinogenesis, 1992
- p53 in the Diagnosis of Human NeoplasiaJNCI Journal of the National Cancer Institute, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Comparative Study of Harvey-RAS Oncogene Expression with Conventional Clinicopathologic Parameters of Breast CancerOncology, 1986